Calamos Advisors LLC Boosts Stock Holdings in Colgate-Palmolive (NYSE:CL)

Calamos Advisors LLC increased its position in shares of Colgate-Palmolive (NYSE:CL) by 0.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 302,648 shares of the company’s stock after buying an additional 805 shares during the period. Calamos Advisors LLC’s holdings in Colgate-Palmolive were worth $27,514,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. State Street Corp boosted its stake in shares of Colgate-Palmolive by 3.8% in the third quarter. State Street Corp now owns 48,436,276 shares of the company’s stock worth $5,028,170,000 after acquiring an additional 1,784,411 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Colgate-Palmolive by 2.8% in the 3rd quarter. Geode Capital Management LLC now owns 20,193,331 shares of the company’s stock valued at $2,095,325,000 after purchasing an additional 552,949 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its stake in Colgate-Palmolive by 6.2% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 9,526,990 shares of the company’s stock worth $988,997,000 after purchasing an additional 557,492 shares during the last quarter. Barclays PLC grew its holdings in shares of Colgate-Palmolive by 38.7% during the third quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock worth $793,542,000 after buying an additional 2,132,747 shares in the last quarter. Finally, FMR LLC lifted its stake in shares of Colgate-Palmolive by 65.6% in the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock worth $700,642,000 after buying an additional 2,674,807 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

CL stock opened at $87.05 on Tuesday. The stock’s fifty day simple moving average is $91.35 and its 200-day simple moving average is $97.15. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 52-week low of $82.68 and a 52-week high of $109.30. The stock has a market capitalization of $71.12 billion, a price-to-earnings ratio of 24.73, a price-to-earnings-growth ratio of 3.61 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the business earned $0.87 EPS. Equities research analysts expect that Colgate-Palmolive will post 3.74 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.30%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 56.82%.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on CL. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Raymond James restated an “outperform” rating and issued a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a research note on Monday. Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. JPMorgan Chase & Co. lowered their target price on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a research note on Monday. Finally, TD Cowen decreased their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, Colgate-Palmolive has an average rating of “Hold” and a consensus target price of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.